Oderkerk TJ

No ORCID on file · 1 paper in corpus
2025
AJOG global reports ·doi:10.1016/j.xagr.2025.100474

BackgroundIn the first month after the insertion of the 52-mg levonorgestrel intrauterine device, irregular vaginal bleeding often occurs. In 6% to 18% of 52-mg levonorgestrel intrauterine device users, irregular vaginal bleeding reoccurs o…